Advertisement

Der Aufbau eines flexiblen Programms zur Wirkungsbeurteilung von Massnahmen der Fertilitätskontrolle

  • Howard W. Ory
  • Carl W. TylerJr.
  • Roger W. Rochat
  • Willard CatesJr.
Chapter
Part of the Medizinische Informatik und Statistik book series (MEDINFO, volume 7)

Zusammenfassung

In den Vereinigten Staaten waren 1973 ein Fünftel aller Geburten (13,9 Mill.) von Müttern im Alter von 15–44 Jahren unerwünscht zum Zeitpunkt der Empfängnis (22). Es überrascht deshalb nicht, daß 18,5 Mill, verheiratete amerikanische Frauen eine der reversiblen oder irreversiblen Kontrazeptionsmethoden anwenden (23), und daß eine zusätzliche Million Frauen legale Schwangerschaftsunterbrechungen zur Verhinderung einer unerwünschten Geburt vornehmen lassen (7). Die Family Planning Evaluation Division (FPED) des United States Center for Disease Control (CDC) ist bestrebt, die Wirkung von Familienplanungsprogrammen zu evaluieren, die Effektivität von Techniken zur Geburtenkontrolle einzuschätzen und die Sicherheit (Nebenwirkungsfreiheit) dieser Maßnahmen der Fertilitätskontrolle zu bestimmen. Deshalb entfaltet das CDC Aktivitäten im öffentlichen Gesundheitswesen unter folgender Zielsetzung:
  1. 1.

    Es soll sichergestellt werden, daß jede Schwangerschaft zur Geburt eines erwünschten Kindes führt

     
  2. 2.

    Tod als Folge von Schwangerschaftsunterbrechung soll verhindert und Morbidität als Folge von Schwangerschaftsunterbrechung soll unter Kontrolle gehalten werden

     
  3. 3.

    Tod als Folge von Kontrazeption oder Sterilisation soll verhindert und Morbidität aus diesen Ursachen soll kontrolliert werden.

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Berger, G.S.; Gibson J.J.; Harvey, R.P. et al.: One death and a cluster of febrile complications related to saline abortions. Obstet Gynecol 41 (1973) 121–126Google Scholar
  2. 2.
    Berger, G.S.; Bourne, J.P.; Tyler, C.W.jr. et al.: Termination of pregnancy by “super coils”: morbidity associated with a new method of second-trimester abortion. Am J Obstet Gynecol 116 (1973) 297–304Google Scholar
  3. 3.
    Bernstein, G.S.; Israel, R.; Seward, P. et al.: Clinical experience with the Cu-7 intrauterine device. Contraception 6 (1972) 99–107CrossRefGoogle Scholar
  4. 4.
    Bernstein, G.S.; Seward, P.: Daily Chlormadinone acetate as an oral contraceptive. Contraception 5 (1972) 369–388CrossRefGoogle Scholar
  5. 5.
    Cates, W.jr.; Grimes, D.A.; Smith, J.C. et al.: The risk of dying from legal abortion, United States, 1972–1975. Int J Gynaecol Obstet (in press)Google Scholar
  6. 6.
    Cates, W.jr.; Ory, H.W.; Rochat, R.W. et al.: The intrauterine device and deaths from spontaneous abortion. N Engl J Med 295 (1976) 1155–1159CrossRefGoogle Scholar
  7. 7.
    Center for Disease Control: Abortion Surveillance 1975. Atlanta, Center for Disease Control, 1977Google Scholar
  8. 8.
    Cheng, M.C.E.; Wong, Y.M.; Rochat, R.W. et al.: Sterilization failures in Singapore: an examination of ligation techniques and failure rates. Stud Fam Plann 8 (1977) 109–115CrossRefGoogle Scholar
  9. 9.
    Faulkner, W.L.; Ory, H.W.: Intrauterine devices and acute pelvic inflammatory disease. JAMA 235 (1976) 1851–1853CrossRefGoogle Scholar
  10. 10.
    Greene, G.R.; Sartwell, P.E.: Oral contraceptive use in patients with thromboembolism following surgery, trauma, or infection. Am J Public Health 62 (1972) 680–685CrossRefGoogle Scholar
  11. 11.
    Greenblatt, D.J.; Ory, H.W.; Levy, M.: Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Lancet 1973, 1399–1404Google Scholar
  12. 12.
    Grimes, D.A.; Schulz, K.F.; Cates, W.jr. et al.: Midtrimester abortion by dilatation and evacuation: a safe and practical alternative. N Engl J Med 296 (1977) 1141–1145CrossRefGoogle Scholar
  13. 13.
    Grimes, D.A.; Schulz, K.F., Cates, W.jr. et al.: Midtrimester abortion by intraamniotic prostaglandin: safer than saline? Obstet Gynecol 49 (1977) 612–616Google Scholar
  14. 14.
    Grimes, D.A.; Cates, W.jr.: Deaths from paracervical anesthesia used for first-trimes ter abortion. N Engl J Med 295 (1976) 1397–1399CrossRefGoogle Scholar
  15. 15.
    Hepatic Branch, Armed Forces Institute of Pathology, Family Planning Evaluation Division, Center for Disease Control: Increased risk of hepatocellular adenoma in women with long-tern use of oral contraception. Morbidity and Mortality Weekly Report 26 (1977) 293–294Google Scholar
  16. 16.
    Kahan, R.S.; Baker, L.D.; Freeman, M.G.: The effect of legalized abortion on morbidity resulting from criminal abortion. Am J Obstet Gynecol 121 (1975) 114–116Google Scholar
  17. 17.
    Kahn, H.S.; Tyler, C.W.jr.: IUD insertion practices in the United States and Puerto Rico, 1973. Fam Plann Perspect 7 (1975) 209–212CrossRefGoogle Scholar
  18. 18.
    Kahn, H.S.; Tyler, C.W.jr.: IUD-related hospitalizations: United States and Puerto Rico, 1973. JAMA 234 (1975) 53–56CrossRefGoogle Scholar
  19. 19.
    Kahn, H.S.; Tyler, C.W.jr.: Mortality associated with use of IUDs. JAMA 234 (1975) 57–59CrossRefGoogle Scholar
  20. 20.
    Kahn, H.S.; Tyler, C.W.jr.: An association between the Dalkon shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device-related disorders. Am J Obstet Gynecol 125 (1976) 83–86Google Scholar
  21. 21.
    Kay, C.R.: Oral contraceptives and health. The Royal College of General Practitioners, New York: Pitman 1974Google Scholar
  22. 22.
    Munson, M.L.: Wanted and unwanted births reported by mothers 15–44 years of age: United States, 1973. Hyattsville, Maryland: National Center for Health Statistics 1977Google Scholar
  23. 23.
    National Center for Health Statistics: Contraceptive utilization among currently married women 15–44 years of age: United States, 1973. Monthly Vital Statistics Report 25(1976)1–24Google Scholar
  24. 24.
    Ory, H., Boston Collaborative Drug Surveillance Program: Functional ovarian cysts and oral contraceptives. JAMA 228 (1974) 68–69CrossRefGoogle Scholar
  25. 25.
    Ory, H.W.; Cole, P.T.; MacMahon, B. et al.: Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med 294 (1976) 419–422CrossRefGoogle Scholar
  26. 26.
    Ory, H.W.: A review of the association between intrauterine devices and acute pelvic inflammatory disease. Journal of Reproductive MedicineGoogle Scholar
  27. 27.
    Ory, H.W.: Oral contraceptive use and breast diseases. In: Garattini, S.; Berendes, H.W. (eds): Pharmacology of Steroid Contraceptive Drugs. New York: Raven Press 1977, 179–183Google Scholar
  28. 28.
    Ory, H.W.: The association of oral contraceptives and myocardial infarction: a review. JAMA 237 (1977) 2619–2622CrossRefGoogle Scholar
  29. 29.
    Sartwell, P.E.; Masi, A.T.; Arthes, F.G. et al.: Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am J Epidemiol 90 (1969) 365–380Google Scholar
  30. 30.
    Seward, P.N.; Israel, R.; Ballard, C.A.: Ectopic pregnancy and intrauterine contraception: a definite relationship. Obstet Gynecol 40 (1972) 214–217Google Scholar
  31. 31.
    Seward, P.N.; Ballard, C.A.; Ulene, A.L.: The effect of legal abortion on the rate of septic abortion at a large county hospital. Am J Obstet Gynecol 115 (1973) 335–338Google Scholar
  32. 32.
    Slaughter, L.; Ballard, C.A.: Midtrimester abortion with intramuscular injection of 15-methyl-prostaglandin F2a. Contraception 11 (1975) 533–540CrossRefGoogle Scholar
  33. 33.
    Tyler, C.W.jr.; Cates, W.jr.: Legal abortion in the United States: its effect on the health of women, in: Proceedings of the Pathfinder Fund Conference on New Developments in Fertility Regulation, Airlie, 28–30 March 1976. Boston: Pathfinder Fund 1976, 143–149Google Scholar
  34. 34.
    Wright, N.H.; Laemmle, P.: Acute pelvic inflammatory disease in an indigent population. Am J Obstet Gynecol 101 (1968) 979–990Google Scholar
  35. 35.
    Vessey, M.: A long-term follow-up study of women using different methods of contraception — A interim report. J Bio Sc Vol.8, No.4 (1976) 373–427Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1978

Authors and Affiliations

  • Howard W. Ory
  • Carl W. TylerJr.
  • Roger W. Rochat
  • Willard CatesJr.

There are no affiliations available

Personalised recommendations